PA
AVDL

Perceptive Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Perceptive Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-590,000
Closed -$5.4M – 97
2023
Q1 		$5.4M Buy
+590,000
New +$4.85M 0.16% 75
2020
Q3 		– Sell
-8,681
Closed -$133K – 131
2020
Q2 		$133K Hold
8,681
– – ﹤0.01% 124
2020
Q1 		$76K Hold
8,681
– – ﹤0.01% 111
2019
Q4 		$66K Buy
+8,681
New +$45.9K ﹤0.01% 111
2018
Q2 		– Sell
-1,295,841
Closed -$9.45M – 129
2018
Q1 		$9.45M Sell
1,295,841
-1,096,000
-46% -$9.64M 0.26% 61
2017
Q4 		$19.6M Buy
2,391,841
+842,836
+54% +$7.9M 0.65% 41
2017
Q3 		$16.3M Buy
1,549,005
+119,891
+8% +$1.14M 0.62% 38
2017
Q2 		$15.8M Buy
1,429,114
+20,874
+1% +$210K 0.79% 37
2017
Q1 		$13.6M Buy
1,408,240
+20,000
+1% +$200K 0.78% 34
2016
Q4 		$14.4M Buy
1,388,240
+24,529
+2% +$270K 1.03% 25
2016
Q3 		$16.9M Buy
+1,363,711
New +$17.8M 1.09% 21
2015
Q1 		– Sell
-644,111
Closed -$3.68M – 158
2014
Q4 		$3.68M Buy
644,111
+34,111
+6% +$487K 0.31% 66
2014
Q3 		$8.73M Sell
610,000
-190,000
-24% -$2.73M 0.88% 30
2014
Q2 		$12M Hold
800,000
– – 1.18% 27
2014
Q1 		$10.7M Buy
+800,000
New +$8.57M 1.13% 29

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Perceptive Advisors's AVDL Position: Q2 2023 in Review

Perceptive Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q2 2023, closing a stake of 590,000 shares — an estimated $5.4M sold.

Perceptive Advisors first reported a position in AVDL in Q1 2014 and held it in 15 quarters. The position peaked at $19.6M in Q4 2017. 101 funds tracked by Wall St. Rank hold AVDL as of Q2 2023.

  • Perceptive Advisors reported no remaining Avadel Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Perceptive Advisors sold 590,000 Avadel Pharmaceuticals shares in Q2 2023, an estimated $5.4M.
  • Perceptive Advisors first reported a position in Avadel Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Perceptive Advisors's Avadel Pharmaceuticals position peaked at $19.6M in Q4 2017.
  • 101 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2023.

Based on Perceptive Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.